Government looks to include biosimilars in price controls
British Biosimilars Association say the proposals “make no sense”
Read More
Author: George Underwood
GSK appoints HSBC’s Iain Mackay as CFO
Iain will join the company on 14 Janurary 2019 and will also be appointed as an Executive Director to the Board
Read More
MHRA clarifies post-Brexit clinical trials rules
Agency expects close cooperation with EU and for the new Clinical Trials Regulation to apply in UK
Read More
Janssen and Immune Bioscience team up for oncology antibodies
Companies will investigate targets that historically have been a challenge for therapeutic development
Read More
Regeneron and Bluebird Bio collaborate on T-cells in $100 million deal
Companies will leverage each others technology platforms against six initial targets
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
